ArticleMolecular biotechnology2026
Synthesis of ZIF-67 Nanoparticles for Camel Whey Protein Delivery: Promising Antioxidant, Anti-inflammatory, Anticancer Effects, and Anti-biofilm Activity.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Camel whey protein (CWP) offers various health benefits, including immune enhancement, anti-inflammatory, anticancer, and antibacterial properties. It also possesses antioxidant activity. However, its limited efficacy and stability restrict its broader application. Metal-organic frameworks (MOFs) are crystalline materials composed of multiple organic groups and metal ions, known for their unique structural properties. In this study, we aimed to synthesize and evaluate the biological activity of a CWP-Co-MOF conjugate. The structural characterization of the synthesized materials was conducted using X-ray diffraction (XRD), Fourier-transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), and energy-dispersive X-ray (EDX) analysis. The comparison of the XRD and FTIR patterns of ZIF-67, CWP and CWP-Co-MOF conjugate indicate successful conjugation of CWP with ZIF-67, confirming the structural integrity of the conjugate. The EDX maps further corroborate the effective conjugation of CWP with ZIF-67. The conjugated CWP-MOF nanoparticles (NPs) exhibited promising antioxidant activity, as assessed by the DPPH assay. Furthermore, they showed more potent anti-inflammatory effects in LPS-induced BV2 microglial cells and superior anticancer activity against HepG2 and Caco-2 cell lines, as determined by the MTT assay and flow cytometry, compared to free CWP. Additionally, the CWP-MOF-NPs exhibited enhanced antimicrobial properties and increased efficacy as an anti-biofilm agent against pathogenic bacteria.
Indexed as
Identifiers
40468143What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.